Course: Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities
CME Credits: 0.00
Released: 2025-10-31
In recent years, a deeper understanding of non-melanoma skin cancer pathogenesis has driven major therapeutic advances, including the approval of multiple immune checkpoint inhibitors for advanced and metastatic disease. As new treatment options continue to emerge, it is essential for oncology clinicians serving patients from rural and underserved communities to stay current with evolving management strategies. However, limited time, resources, and access to multidisciplinary care can make this difficult. In this on-demand CME/CE activity, experts will review the latest clinical evidence and guideline recommendations for systemic therapies in advanced and metastatic non-melanoma skin cancer through case-based discussions. The program will also highlight strategies to overcome barriers to care, optimize management of treatment-related adverse events, and address the unique challenges faced by patients in rural and underserved settings. This enduring activity is a recorded session from Oncology Congress that took place on October 25, 2025.
Upon completion of this activity, participants should be better able to:
View Full Course